Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
gptkb:monoclonal_antibody |
| gptkbp:ATCCode |
none (as of 2024)
|
| gptkbp:CASNumber |
1800016-26-1
|
| gptkbp:clinicalTrialPhase |
Phase 3
|
| gptkbp:developedBy |
gptkb:AstraZeneca
|
| gptkbp:intendedUse |
treatment of chronic kidney disease
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:target |
interleukin-6 (IL-6)
|
| gptkbp:UNII |
6Q1K1Q1Q1F
|
| gptkbp:bfsParent |
gptkb:Corvidia_Therapeutics
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
ziltivekimab
|